Appendix A

The formulas used to estimate sample size requirements are provided in this appendix. Also provided are illustrative calculations relative to the Diabetes Control and Complications Trial described in Chapter 7: Clinical Trials.

Prior to undertaking this study, the investigators specified an alpha level (0.05, or 5%), statistical power (90%, and thus a beta level of 10%), and the outcome difference that should be detected by the trial (a reduction in the proportion of patients diagnosed with diabetic retinopathy from 20% to 10%). The baseline proportion of subjects who would develop retinopathy is derived from previous literature. The amount of reduction in retinopathy is based on clinical judgment; the following question was posed: “What would be a clinically important difference in the proportion of patients who would suffer this complication?”

The equation for sample size for a comparison of two proportions is as follows:

where n is the number of subjects for each treatment group, πc and πt are the proportion of patients that develops retinopathy within 5 years in the control group (standard therapy) and treatment group (intensive therapy), respectively, and za and zb are the values that include alpha in the two tails and beta in the lower tail of the standard normal distribution. These values can be determined from tables available in most statistical texts (see Dawson and Trapp, 2004; complete publication data can be found at the end of Chapter 7: Clinical Trials). The value for a type I error of 5% is 1.96, and the zb value for a type II error of 10% is –1.28. As the acceptable level of error decreases, za and zb increase.

Note that in equation (1), the larger the za and zb—that is, the smaller the acceptable type I and type II errors—the larger the sample size required; also the smaller the difference in πc and πt, the larger the sample size required. What may not be so intuitively obvious is the relation of sample size to the distance of πc from 0.5. The part of the equation πc(1 – πc) is maximized, and therefore the numerator is greater when πc = 0.5. Movement of πc away from 0.5 reduces the required sample size.

If we expected the proportion of patients on standard insulin therapy for diabetes that would develop retinopathy by year 5 to be 0.20, and we wanted this trial to be able to detect a reduction in retinopathy at 5 years from 0.20 to 0.10, then the sample size would be calculated as follows:

and n = 305. Therefore, a total of 610 subjects equally divided between groups would be required to answer the following question: “Is there a reduction in the rate of retinopathy at ...

Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.

Ok

## Subscription Options

### AccessPharmacy Full Site: One-Year Subscription

Connect to the full suite of AccessPharmacy content and resources including 30+ textbooks such as Pharmacotherapy: A Pathophysiologic Approach and Goodman & Gilman's The Pharmacological Basis of Therapeutics, high-quality videos, images, and animations, interactive board review, drug and herb/supplements databases, and more.